Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-166,114
Closed -$216K 2311
2024
Q1
$216K Buy
+166,114
New +$174K 0.01% 1641
2022
Q4
Sell
-69,723
Closed -$152K 2064
2022
Q3
$152K Sell
69,723
-49,677
-42% -$171K 0.01% 1396
2022
Q2
$418K Buy
119,400
+2,000
+2% +$7.47K 0.02% 925
2022
Q1
$592K Sell
117,400
-14,058
-11% -$71.2K 0.03% 732
2021
Q4
$825K Buy
+131,458
New +$898K 0.05% 458
2021
Q2
Sell
-217,887
Closed -$1.32M 1413
2021
Q1
$1.32M Buy
+217,887
New +$1.68M 0.12% 181

Other funds holding VXRT

Jump Financial's VXRT Position: Q2 2024 in Review

Jump Financial sold out of Vaxart (VXRT) in Q2 2024, closing a stake of 166,114 shares — an estimated $216K sold.

Jump Financial first reported a position in VXRT in Q1 2021 and held it in 6 quarters. The position peaked at $1.32M in Q1 2021. 100 funds tracked by Wall St. Rank hold VXRT as of Q2 2024.

  • Jump Financial reported no remaining Vaxart position as of Q2 2024 after selling out during the quarter.
  • Jump Financial sold 166,114 Vaxart shares in Q2 2024, an estimated $216K.
  • Jump Financial first reported a position in Vaxart in Q1 2021 and held it in 6 quarters.
  • Jump Financial's Vaxart position peaked at $1.32M in Q1 2021.
  • 100 funds tracked by Wall St. Rank held Vaxart as of Q2 2024.

Based on Jump Financial's 13F filing for Q2 2024, filed 14 Aug 2024.